Data / Form D filings / Eldec Pharmaceuticals, Inc.
Eldec Pharmaceuticals, Inc.: Form D filing
Eldec Pharmaceuticals, Inc., a pharmaceuticals company in Chapel Hill, NC, filed a Form D with the SEC in 2026. The latest, on February 12, 2026, reports $200,000 sold of a $1.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 510 MEADOWMONT VILLAGE CIRCLE SUITE 364, Chapel Hill, NC, 27517
- Phone
- (919) 219-1113
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2110508
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | New notice | $1,500,000 | $200,000 | $1,300,000 | 1 | Feb 11, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Schotzinger | Executive Officer, Director | |
| Robert Tarran | Executive Officer, Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Feb 9, 2026 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Eldec Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.